Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yutaka Kozu has a total of 174 co-authors. Here are the top co-authors by number of shared publications:

  • Yasuhiro Gon

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    13 shared publications
  • Hisato Hiranuma

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    9 shared publications
  • Yusuke Kurosawa

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    8 shared publications
  • Shuichiro Maruoka

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    7 shared publications
  • Yasuhiro Gon

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    7 shared publications
  • Shiho Yamada

    Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    6 shared publications

Latest Publications

  • Open Access

    Double-stranded RNA sensing in airway basal cells impairs subsequent epithelial barrier formation via TLR3/TRIF

    by Shinichi Okamoto, Shuichiro Maruoka, Kota Tsuya, Mari Hikichi, Shiho Yamada, Yusuke Kurosawa, Yutaka Kozu, Yasuhiro Gon

    Background: Double-stranded viral RNA disrupts the airway epithelial barrier; however, its specific impact on basal progenitor cells remains unknown. In this study, we stimulated undifferentiated normal human bronchial epithelial cells and VA10 cells, which function as basal cells, with the Toll-like receptor 3 (TLR3) ligand polyinosinic: polycytidylic acid (poly I: C). The cells were subsequently cultured at an air-liquid interface (ALI) to evaluate the airway epithelial barrier integrity and perform global gene expression analysis. Results: Poly I: C stimulation significantly decreased transepithelial electrical resistance and reduced the expression of barrier-related genes. This barrier dysfunction was attenuated by silencing TLR3 or TIR-domain-containing adapter-inducing interferon-β (TRIF). Transcriptomic analysis identified distinct gene-expression patterns at the two time points examined. At day 10, replicated microarray analysis showed increased expression of inflammation- and remodeling-associated genes. At day 3, an exploratory pooled analysis, with individual genes validated by RT-qPCR in separate, non-pooled wells, showed induction of interferon-stimulated genes together with reduced expression of genes required for epithelial differentiation and barrier formation. Conclusions: In airway basal cells, double-stranded RNA impaired subsequent epithelial barrier formation, and this impairment required TLR3 and TRIF during the exposure window. The accompanying transcriptional changes differed between the two time points examined: an antiviral program at day 3, coinciding with reduced expression of differentiation- and barrier-associated genes, and increased expression of inflammation- and remodeling-associated genes at day 10. As a hypothesis to be tested directly, we propose that dsRNA sensing during this early window redirects basal cell differentiation. These findings suggest a mechanism by which dsRNA sensing in airway basal cells may contribute to persistent barrier vulnerability. Validation using live respiratory viruses, and in primary cells from multiple donors, is required before this mechanism can be extended to viral infections.

  • Open Access

    Alleviating Depressive Symptoms Through Continuous Positive Airway Pressure Therapy: Long-Term Effects on Patients with Obstructive Sleep Apnea

    by Yutaka Kozu, Hisato Hiranuma, Yasunori Itoda, Yusuke Jinno, Shun Yokota, Shuichiro Maruoka, Yasuhiro Gon

    Obstructive sleep apnea (OSA) increases the risk of physical and psychological comorbidities, including depression. Although the short-term impact of continuous positive airway pressure (CPAP) therapy on depressive symptoms is established, its long-term psychological impact beyond 2 years remains underexplored. To evaluate the impact of long-term CPAP therapy on depressive symptoms in patients with OSA, focusing on Self-Rating Depression Scale (SDS) subdomain changes, as well as the influence of demographic and clinical variables such as age and sex. We enrolled 170 patients with OSA who underwent polysomnography and received CPAP for ≥ 6 months at the Nihon University Itabashi Hospital Sleep Center. Depression severity was measured using the SDS, and subgroup analyses assessed associations between changes in SDS scores and clinical parameters (age, sex, CPAP adherence, and sleep-related indices). Total SDS scores significantly declined from 40.2 to 37.5 in patients using CPAP for ≥2 years. Improvement was most pronounced in the cognitive and behavioral subdomains (e.g., fatigue, motivation, and decision-making) and was statistically significant among male patients, whereas female patients showed a nonsignificant trend toward improvement. No significant associations were observed between baseline characteristics (e.g., age and comorbidities) and SDS score changes. Multivariate analysis confirmed these improvements were not solely attributable to a single subdomain. Long-term CPAP therapy was associated with modest improvements in depressive symptoms in patients with OSA, particularly in cognitive and behavioral domains. In exploratory analyses, benefits appeared more evident in males, but these findings should be interpreted with caution given the limited female sample size.

  • Open Access

    Upper limb paresis due to herpes zoster successfully managed in an outpatient setting: a case report

    by Yutaka Kozu, Hitoshi Kozu, Yasuhiro Gon

    Background: Reactivation of the varicella zoster virus can result in a neurological complication, including segmental zoster paresis. Outpatient management of upper limb paresis due to herpes zoster is rarely reported, making this case clinically relevant. Case presentation: We describe a 70-year-old Japanese woman initially diagnosed with cervical spondylosis who later developed a vesicular rash and progressive left arm weakness. Neurological examination and nerve conduction studies revealed motor involvement consistent with segmental zoster paresis. She was treated with antiviral therapy, physical rehabilitation, analgesics, and adjunctive vitamin supplementation, leading to full recovery. Conclusion: This case shows the feasibility of outpatient management in select cases of segmental zoster paresis and the importance of timely intervention. Herpes zoster should be considered in the differential diagnosis of acute unilateral arm paresis, especially in cases involving radicular pain.

  • Simultaneous estimation of sleep duration and sleep apnea–hypopnea using millimeter-wave radar

    by Mamiko Hoshi, Yutaka Kozu, Shigeaki Okumura, Daisuke Endo, Tatsuya Ito, Kazuma Nagata, Hisato Hiranuma, Ryuji Furihata, Susumu Sato, Toyohiro Hirai, et al.

    Comorbid insomnia and sleep apnea is increasingly recognized, yet detection remains challenging due to limitations of contact-based monitoring such as polysomnography (PSG) and wearable devices. Millimeter-wave radar (MWR) may provide a non-contact alternative for simultaneous assessment of sleep-disordered breathing and sleep duration. This study evaluated the accuracy of MWR in estimating the respiratory event index (REI) and sleep duration, and identified optimal post-movement exclusion windows to enhance concordance with PSG standards. Sixty-two adults underwent overnight PSG with concurrent MWR recording. REI and estimated sleep duration (ESD) were calculated after excluding data within 1, 2, or 3 min following large body movements. Agreement between REI and PSG-derived apnea–hypopnea index (AHI), and between ESD and PSG-derived total sleep time (TST), was assessed using Bland–Altman analysis. The 3-min exclusion window yielded the smallest bias and narrowest limits of agreement for REI (mean bias = + 0.1 events/h; 95% confidence interval = − 8.2 to 8.4), matching PSG-derived AHI (18.9 ± 16.9 vs. 19.0 ± 14.4 events/h). In contrast, the 1-min exclusion window provided the best agreement for sleep duration (mean bias = − 26 min; 95% confidence interval = − 72 to 20), aligning with PSG-derived TST (422 ± 80 vs. 396 ± 71 min). MWR enables simultaneous, non-contact estimation of sleep-disordered breathing and sleep duration with clinically acceptable concordance to PSG. Metric-specific optimization—3 min for REI and 1 min for ESD—supports MWR as a low-burden tool for screening and monitoring in clinical and home environments.

  • Open Access

    ATP-related purinergic signaling via P2Y12 contributes to airway epithelial barrier integrity

    by Kota Tsuya, Shuichiro Maruoka, Shinichi Okamoto, Sotaro Shikano, Mari Ujike, Shiho Yamada, Yusuke Kurosawa, Kenji Mizumura, Yutaka Kozu, Yasuhiro Gon

    Background: The airway epithelial barrier, which defends against external pathogens, is compromised in bronchial asthma. This study investigated the roles of adenosine triphosphate (ATP) and specific purinergic receptors in airway epithelial barrier function. Using the 16HBE14o- human airway epithelial cell line, we measured barrier integrity using transepithelial electrical resistance and the apparent paracellular permeability coefficient. Results: ATP enhanced barrier integrity in a dose-dependent manner without affecting cell proliferation. Real-time PCR revealed an increased expression of tight and adherens junction proteins, including E-cadherin and occludin, following ATP stimulation. Our findings suggest that P2Y12 contributes to ATP-related purinergic signaling associated with enhanced airway epithelial barrier integrity. Conclusions: These findings suggest that ATP-related purinergic signaling via P2Y12 may contribute to the regulation of airway epithelial barrier integrity in vitro. Further studies in more physiologically relevant systems are warranted to determine the clinical relevance of these observations.


  • Open Access

    Sex-Specific Differences in Gut Microbiota Composition in Adult Patients with Bronchial Asthma

    by Chihiro Hirano, Yutaka Kozu, Yusuke Jinno, Yusuke Kurosawa, Shiho Yamada, Kouta Hatayama, Kanako Kono, Kenji Mizumura, Motoyasu Iikura, Shuichiro Maruoka, et al.

    Background: Gut microbiota dysbiosis has been associated with childhood asthma; however, its role in adult bronchial asthma (BA), particularly in Japanese populations, remains unclear. The potential influence of sex-based differences also warrants investigation. We aimed to investigate the association between gut microbiota composition and adult BA in a Japanese cohort, focusing on sex-specific differences. Methods: Stool samples from 108 Japanese adults with BA (48 male and 60 female individuals) and 210 healthy controls (90 male and 120 female individuals) were analyzed using 16S rRNA gene sequencing. Analyses were stratified by sex. β-diversity was assessed using non-metric multidimensional scaling and permutational multivariate analysis of variance. Genus-level taxonomic comparisons were conducted using the ANOVA-Like Differential Expression version 2 tool on centered log-ratio-transformed data. Results: β-diversity significantly differed between the groups among both male and female individuals. In male individuals, 11 taxa had absolute effect sizes of ≥0.2. In female individuals, 19 taxa met this threshold, with 8 reaching significance after Benjamini–Hochberg correction. Streptococcus and Blautia were enriched in the BA group in both sexes, whereas other taxa showed sex-specific patterns, such as Veillonella in male and Flavonifractor and Eggerthella in female individuals. Several short-chain fatty acid (SCFA)-producing taxa were depleted in the BA group. Conclusions: Our findings suggest that gut microbiota dysbiosis occurs in Japanese adults with BA, characterized by enrichment of taxa associated with respiratory diseases and depletion of SCFA-producing bacteria. The observed patterns highlight the importance of considering sex-specific differences in future research.


  • Impact of telemedicine in long-term CPAP therapy: A twelve-month follow-up study in Japan utilizing propensity score matching

    by Daisuke Endo, Toshiki Akahoshi, Kenichi Nagaoka, Eri Hagiwara, Yuki Okamoto, Yasuhito Nagata, Ayako Hori, Tatsuya Ito, Akihito Uematsu, Yoshio Watanabe, et al.

  • Open Access

    Novel Humanized Mouse Model for Steroid‐Resistant Asthma

    by Shiho Yamada, Shuichiro Maruoka, Shota Toyoshima, Yusuke Kurosawa, Ryosuke Ozoe, Yutaka Kozu, Kenji Mizumura, Yoshimichi Okayama, Ryoji Ito, Yasuhiro Gon

  • Clinical outcomes, safety, and potential prognostic factors of noninvasive respiratory support in patients with COVID-19: A Japanese multicenter observational study

    by Jiro Ito, Toshiki Yokoyama, Aiko Tanaka, Ryutaro Seo, Keisuke Tomii, Clara So, Shinyu Izumi, Yutaka Kozu, Kazuo Chin, Yasuhiro Gon, et al.


  • Open Access

    Gut Microbiota Dysbiosis in Japanese Female Patients with Nontuberculous Mycobacteria-Associated Lung Disease: An Observational Study

    by Kanako Kono, Yutaka Kozu, Shun Yokota, Kouta Hatayama, Kenji Mizumura, Shuichiro Maruoka, Hiroaki Masuyama, Yasuhiro Gon

    Background/Objectives: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is treated using a combination of multiple antimicrobial agents and prolonged therapy; however, recurrence and reinfection rates remain high. Susceptibility to NTM-PD is not fully understood. We aimed to investigate the association between NTM-PD and gut microbiota and determine the impact of antimicrobial therapy on the composition of the gut microbiota. Methods: We analyzed the gut microbiota of 20 Japanese females with NTM-PD (mean age: 67.9 years; range: 50–80 years) at different treatment stages—before, during, and at recurrence—alongside 20 healthy individuals, using 16S rRNA gene amplicon sequencing. Results: Subgroup A (pre-treatment) showed a small difference in β-diversity when compared with the healthy control (HC) group, while no significant differences in α-diversity were observed. Subgroup B (during treatment) exhibited a larger difference in β-diversity compared with the HC group, along with a decrease in α-diversity. The α-diversity of the gut microbiota in Subgroup C (at recurrence) was lower than that in Subgroup A but higher than that in Subgroup B. In Subgroups A and C, the bacterial taxa Sutterella, Adlercreutzia, Odoribacter, and Prevotella had decreased relative abundance, while Erysipelatoclostridium, Massilimicrobiota, Flavonifractor, Eggerthella, and Fusobacterium had increased relative abundance compared to those in the HC group. Conclusions: The loss of normal resident gut bacteria may hinder reacquisition. Treatment may be associated with the persistence of a dysbiotic gut microbiota, fostering susceptibility to NTM-PD. Gut microbiota dysbiosis may heighten susceptibility to NTM-PD, complicate treatment outcomes, and increase the risk of microbiological recurrence following therapy.